April 21, 2021 08:05 AM EDT
Coronavirus

Covid-19 roundup: BioN­Tech ex­ec says new pro­duc­tion sites could be added to meet de­mand — re­port; Giv­ing up on the EC, Val­ne­va looks to in­di­vid­ual coun­tries for vac­cine sup­ply deals

Nicole DeFeudis

Editor

BioN­Tech CFO Sierk Po­et­ting says he isn’t rul­ing out the con­struc­tion of new pro­duc­tion sites to meet de­mand for its Pfiz­er-part­nered Covid-19 vac­cine.

Po­et­ting told …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times